Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.a

Pneumonitis (ILD)

See also under pattern methotrexate-Ia

Publications

Gökten DB, Mercan R

Methotrexate-Associated Hypersensitivity Pneumonitis After 15 Years of Use: A Case Report and Literature Review.

Mediterranean journal of rheumatology 2025 Jun;36;316-321 — 2025 Jun — 316-321

Agarwal M, Sharma KK, Deokar K, Bharti N

Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia.

African journal of thoracic and critical care medicine 2022;28; — 2022

Conway R, Low C, Coughlan RJ, O'Donnell MJ, Carey JJ

Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Arthritis & rheumatology (Hoboken, N.J.) 2014 Apr;66;803-12 — 2014 Apr — 803-12

D'Elia T

Methotrexate-induced pneumonitis: heterogeneity of bronchoalveolar lavage and differences between cancer and rheumatoid arthritis.

Inflammation & allergy drug targets 2014 Feb;13;25-33 — 2014 Feb — 25-33

Massey H, Darby M, Edey A

Thoracic complications of rheumatoid disease.

Clinical radiology 2013 Mar;68;293-301 — 2013 Mar — 293-301

Arakawa H, Yamasaki M, Kurihara Y, Yamada H, Nakajima Y

Methotrexate-induced pulmonary injury: serial CT findings.

Journal of thoracic imaging 2003 Oct;18;231-6 — 2003 Oct — 231-6

Fuhrman C, Parrot A, Wislez M, Prigent H, Boussaud V, Bernaudin JF, Mayaud C, Cadranel J

Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis.

American journal of respiratory and critical care medicine 2001 Oct 01;164;1186-91 — 2001 Oct 01 — 1186-91

Zisman DA, McCune WJ, Tino G, Lynch JP

Drug-induced pneumonitis: the role of methotrexate.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2001 Oct;18;243-52 — 2001 Oct — 243-52

Imokawa S, Colby TV, Leslie KO, Helmers RA

Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients.

The European respiratory journal 2000 Feb;15;373-81 — 2000 Feb — 373-81

Cannon GW

Methotrexate pulmonary toxicity.

Rheumatic diseases clinics of North America 1997 Nov;23;917-37 — 1997 Nov — 917-37

Sharma A, Provenzale D, McKusick A, Kaplan MM

Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis.

Gastroenterology 1994 Jul;107;266-70 — 1994 Jul — 266-70

Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B.

JAMA 1969 Feb 03;207;923-8 — 1969 Feb 03 — 923-8